Evidence map›Paper›PMID 41714115›Full record

ArticleThe FEBS journal2026

Disruption of the ∆40p53/miR-4671-5p/SGSH axis results in intra-S-phase arrest and poor cancer prognosis.

Apala Pal, Pritam Kumar Ghosh, Sahana Ghosh, Sachin Kumar Tripathi, Subrata Patra, Debjit Khan, Arindam Maitra, Saumitra Das

Abstract read
In one paragraph

Article in The FEBS journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Apala PalDepartment of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India.
Pritam Kumar GhoshDepartment of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India.
Sahana GhoshNational Institute of Biomedical Genomics, Kalyani, India.
Sachin Kumar TripathiDepartment of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India.
Subrata PatraNational Institute of Biomedical Genomics, Kalyani, India.
Debjit KhanDepartment of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India.
Arindam MaitraNational Institute of Biomedical Genomics, Kalyani, India.ORCID https://orcid.org/0000-0002-0249-8856
Saumitra DasDepartment of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India.ORCID https://orcid.org/0000-0002-0640-3586

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parsing the functions of the tumor suppressor tumor protein p53 (TP53) is complex due to the multiple isoforms it encodes. ∆40p53, an N-terminally truncated p53 isoform and the only translational isoform, modulates full-length p53 (FLp53) activity and independently regulates targets such as the miR-186-5p/transcriptional repressor protein YY1 axis. To identify additional miRNAs regulated by ∆40p53, we performed small RNA sequencing. We found that ectopic overexpression of ∆40p53, but not FLp53, significantly downregulated miR-4671-5p. Expression of both isoforms at varying ratios revealed that miR-4671-5p may be modulated by FLp53 in a ∆40p53-dependent manner. In silico analysis identified N-sulfoglucosamine sulfohydrolase (SGSH) as a potential miR-4671-5p target. SGSH expression showed an inverse correlation with miR-4671-5p in cancer datasets and had prognostic significance. SGSH mRNA and protein levels were reduced upon miR-4671-5p overexpression or si∆40p53 treatment, confirming regulatory linkage. Functionally, miR-4671-5p overexpression induced intra-S-phase cell cycle arrest, implicating SGSH in cell cycle regulation. These results reveal a previously unknown ∆40p53/miR-4671-5p/SGSH axis that, when dysregulated, induces intra-S-phase cell cycle arrest and may contribute to cancer outcomes. Our findings highlight the distinct regulatory role of ∆40p53, independent of FLp53, in maintaining cellular and metabolic homeostasis via miRNA-mediated mechanisms.

Indexed as

MicroRNAsNeoplasmsS Phase Cell Cycle CheckpointsTumor Suppressor Protein p53Cell Line, TumorGene Expression Regulation, NeoplasticHumansPrognosisProtein IsoformsMicroRNAsProtein IsoformsTP53 protein, humanTumor Suppressor Protein p53∆40p53 rolemiR‐4671‐5p expressionp53 isoformSGSH role in cell cycle regulation

Identifiers

PMID41714115
PMCPMC13440581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.